Ledger.Open graph →
SEC Form D · filed March 4, 2026

IMMUNIC, INC

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, X1
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Thorvald Nagel · New York, NYDirectorJason Tardio · New York, NYExecTamar Howson · New York, NYDirectorGlenn Whaley · New York, NYExecInderpal Singh · New York, NYExecHella Kohlhof · New York, NYExecPatrick Walsh · Bronson, FLExecAndreas Muehler · New York, NYExecBarclay Phillips · New York, NYDirectorDuane Nash · New York, NYDirectorSimona Skerjanec · NEW YORK, NYDirectorDaniel Vitt · New York, NYExec · DirectorRichard Rudick · New York, NYDirectorJoerg Neerman · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗